Vera Therapeutics (VERA) Retained Earnings (2020 - 2026)
Vera Therapeutics posted quarterly Retained Earnings of -$156000.0 for Q1 2026, up 99.97% year-on-year from -$78011.9 in Q1 2025, and down 119.85% on a QoQ basis from $786000.0 in Q4 2025.
Vera Therapeutics (VERA) has 7 years of Retained Earnings data on file, last reported at -$156000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 99.97% year-over-year to -$156000.0; the trailing twelve-month figure through Mar 2026 stood at -$156000.0 (up 99.97% YoY), and the FY2025 full-year result was $786000.0, up 100.17% from the prior year.
- Retained Earnings for Q1 2026 stood at -$156000.0, down from $786000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $786000.0 in Q4 2025 and bottomed at -$669.8 million in Q3 2025.
- The 5-year median for Retained Earnings is -$180.7 million (2022), against an average of -$225.4 million.
- Peak annual rise in Retained Earnings reached 212.05% in 2023, while the deepest fall reached 2026408.33% in 2023.
- A 5-year view of Retained Earnings shows it stood at -$224000.0 in 2022, then jumped by 212.05% to $251000.0 in 2023, then plunged by 183864.94% to -$461.2 million in 2024, then jumped by 100.17% to $786000.0 in 2025, then plunged by 119.85% to -$156000.0 in 2026.
- The last three Retained Earnings figures came in at -$156000.0 (Q1 2026), $786000.0 (Q4 2025), and -$669.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - | -156,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -156,000.00 |
| Dec 31, 2025 | 786,000.00 |
| Sep 30, 2025 | -669.80 Mn |
| Jun 30, 2025 | -589.48 Mn |
| Mar 31, 2025 | -512.90 Mn |
| Dec 31, 2024 | -461.25 Mn |
| Sep 30, 2024 | -417.83 Mn |
| Jun 30, 2024 | -450,000.00 |
| Mar 31, 2024 | -337.50 Mn |
| Dec 31, 2023 | 251,000.00 |
| Sep 30, 2023 | -75,000.00 |
| Jun 30, 2023 | -263.30 Mn |
| Mar 31, 2023 | -243.18 Mn |
| Dec 31, 2022 | -224,000.00 |
| Sep 30, 2022 | -180.70 Mn |
| Jun 30, 2022 | -155.99 Mn |
| Mar 31, 2022 | -12,000.00 |
| Dec 31, 2021 | -124.06 Mn |
| Sep 30, 2021 | -107.21 Mn |
| Jun 30, 2021 | -99.60 Mn |
| Mar 31, 2021 | -96.16 Mn |
| Dec 31, 2020 | -91.45 Mn |